Pricing Log in Create free account

Apollomics Inc. (APLM) vs Connect Biopharma Holdings Limited Sponsored ADR (CNTB)

Apollomics Inc. and Connect Biopharma Holdings Limited Sponsored ADR are both Biotechnology companies. Apollomics Inc. and Connect Biopharma Holdings Limited Sponsored ADR are of similar size ($49.5M and $46.1M). Apollomics Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Apollomics Inc. leads on 9 and Connect Biopharma Holdings Limited Sponsored ADR on 1.

Valuation

Metric APLM CNTB Biotechnology median
P/E n/m n/m 10.60
P/S — 15.30 9.40
P/B n/m 1.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 4.87 9.02
Earnings yield (0.32%) (163.01%) (32.88%)
Free cash flow yield 0.00% (132.91%) (23.13%)

Profitability

Metric APLM CNTB Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (2,346.35%) 0.00%
Net margin 0.00% (2,298.93%) 0.00%
Free cash flow margin 0.00% (2,018.76%) 0.00%
Return on equity 0.00% (140.51%) (51.96%)
Return on assets 0.00% (109.34%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APLM CNTB Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 85.66% (257.14%) 29.88%
Revenue growth, 5-year CAGR 32.77% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM CNTB Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.96 2.37 4.97
Net debt to EBITDA 0.37 0.77 1.01

Dividend

Metric APLM CNTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APLM CNTB Biotechnology median
Market cap 49.49m 46.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack